Observational Study to Assess the Adequacy of Methadone Dosage, in Heroin Addicted Patients in a MMT. (METODO)
Studio Osservazionale Per Valutare l'Adeguatezza Del Dosaggio Del Metadone, Nelle Terapie di Mantenimento, in Rapporto Agli Obbiettivi di Outcome, in Pazienti Tossicodipendenti da Eroina. (METODO)
Sponsor: L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
Listed as NCT02062736, this observational or N/A phase trial focuses on Heroin Addiction and remains completed. Sponsored by L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A., it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.
- Solaris CRO
For direct contact, visit the study record on ClinicalTrials.gov .